Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Installed Building Products Inc

Start price
Target price
Perf. (%)
€105.00
14.02.23
-
14.02.24
70.48%
31.01.24

buy
Grupo Aeroportuario Del Centro Norte Sab De Cv ADR B

Start price
Target price
Perf. (%)
€70.50
14.02.23
-
14.02.24
-4.26%
31.01.24

buy
Lagercrantz Group AB

Start price
Target price
Perf. (%)
€11.05
14.02.23
-
14.02.24
9.41%
31.01.24

buy
Evolution Gaming Group AB

Start price
Target price
Perf. (%)
€118.06
14.02.23
-
14.02.24
-7.96%
31.01.24

buy
Orion Engineered Carbons S.A.

Start price
Target price
Perf. (%)
€20.20
14.02.23
-
14.02.24
2.97%
31.01.24

buy
Verallia SA

Start price
Target price
Perf. (%)
€35.00
14.02.23
-
14.02.24
-5.14%
31.01.24

Inovio Pharma

Start price
Target price
Perf. (%)
€1.47
13.02.23
€0.30
13.02.24
-63.81%
14.02.24

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Cardlytics Inc

Start price
Target price
Perf. (%)
€5.95
13.02.23
€5.00
13.02.24
-12.01%
27.02.23

Capable Management
Innovative
Very low/no dividend yield expected
ROE lower than 10% per year
buy
Baader Bank AG

Start price
Target price
Perf. (%)
€4.49
13.02.23
-
13.02.24
-29.54%
14.02.24

buy
Lannett Co. Inc.

Start price
Target price
Perf. (%)
€0.015
13.02.23
€5.20
-
21.02.23

Could be very worthwhile Investment >20% year
buy
Aixtron SE

Start price
Target price
Perf. (%)
€24.78
11.02.23
€30.00
11.02.24
4.56%
18.02.23

Leading role in innovation
Some uniques
Marubeni Corp

Start price
Target price
Perf. (%)
€12.50
10.02.23
-
06.02.27
50.43%
18.07.24

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
Mynaric AG

Start price
Target price
Perf. (%)
€21.40
10.02.23
-
10.02.24
-14.49%
30.08.23

Probably not worthwhile Investment
Mynaric AG ADR

Start price
Target price
Perf. (%)
€4.84
10.02.23
-
10.02.24
-2.48%
24.08.23

Revenue decline/stagnation expected
buy
Bauer AG

Start price
Target price
Perf. (%)
€6.34
10.02.23
-
10.02.24
-2.52%
24.10.23

buy
Deutsche EuroShop AG

Start price
Target price
Perf. (%)
€21.60
08.02.23
-
08.02.24
-11.57%
09.02.24

buy
BP Prudhoe Bay Royalty

Start price
Target price
Perf. (%)
€11.30
08.02.23
€14.00
08.02.24
-56.37%
24.10.23

Could be very worthwhile Investment >20% year
Very high dividend yield expected
Very valuable balance sheet
Undervalued
MyMD Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.04
07.02.23
€1.00
07.02.24
-7.35%
18.02.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
Bed Bath & Beyond Inc.

Start price
Target price
Perf. (%)
€2.80
07.02.23
€5.00
07.02.24
-39.31%
18.02.23

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
EBIT decline/stagnation expected
buy
Süss MicroTec SE

Start price
Target price
Perf. (%)
€21.45
07.02.23
€24.00
07.02.24
3.73%
11.05.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€2.10
07.02.23
-
07.03.23
18.88%
10.02.23

buy
Reata Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€47.20
07.02.23
€50.00
07.02.25
100.21%
05.05.23

Could be very worthwhile Investment >20% year
buy
Rohm Co. Ltd

Start price
Target price
Perf. (%)
€75.15
07.02.23
€84.00
07.02.24
-3.86%
18.02.23

buy
MannKind Corp.

Start price
Target price
Perf. (%)
€4.76
07.02.23
-
07.02.24
-35.38%
31.01.24

buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€11.30
06.02.23
€20.00
31.12.25
-29.20%
05.05.23

Could be very worthwhile Investment >20% year